S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TSBX Turnstone Biologics Corporation

0.4627

-0.0213 (-4.40%)

Jan 31 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Turnstone Biologics Charts.

Turnstone Biologics (NASDAQ:TSBX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Turnstone Biologics Charts.

Turnstone Biologics Corporation News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 12 November 2024 (3 months ago) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Tuesday 12 November 2024 (3 months ago) • GlobeNewswire Inc.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Tuesday 5 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 11 October 2024 (4 months ago) • Edgar (US Regulatory)

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
Friday 11 October 2024 (4 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 1 October 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 14 August 2024 (6 months ago) • Edgar (US Regulatory)

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
Wednesday 14 August 2024 (6 months ago) • GlobeNewswire Inc.

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
Wednesday 14 August 2024 (6 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 5 June 2024 (8 months ago) • Edgar (US Regulatory)

More Turnstone Biologics Corporation News Articles

UAV Corpoation (PK)

Elite Pharmaceuticals (QB)

Valiant Eagle (PK)

Rennova Health (CE)

Northwest Biotherapeutics (QB)

GBT Technologies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions